Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87,001,862
-
Total 13F shares
-
30,498,627
-
Share change
-
+362,073
-
Total reported value
-
$427,879,020
-
Price per share
-
$14.04
-
Number of holders
-
92
-
Value change
-
-$2,835,798
-
Number of buys
-
39
-
Number of sells
-
56
Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2018
As of 31 Dec 2018,
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,498,627 shares.
The largest 10 holders included
EcoR1 Capital, LLC, BVF INC/IL, GREAT POINT PARTNERS LLC, BlackRock Inc., FMR LLC, EAGLE ASSET MANAGEMENT INC, VICTORY CAPITAL MANAGEMENT INC, Vanguard Group Inc, CARILLON TOWER ADVISERS, INC., and Partner Fund Management, L.P..
This page lists
93
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.